CMS officials have uncovered a dramatic surge in fraudulent transplant claims, prompting an aggressive crackdown on abuse within Medicare and Medicaid.
Through May, investigators identified approximately 4,200 suspicious claims totaling $224 million, triggering an immediate response from federal oversight teams.
Since March, nearly all claims in this category—96%—have been denied as part of a targeted effort to halt deceptive billing practices.
The sharp increase in fraudulent activity, which rose by 7,100%, prompted heightened scrutiny from the White House Anti-Fraud Task Force and CMS leadership.
CMS Administrator Mehmet Oz warned that the scale of the fraud poses a severe financial risk to hospitals, medical providers, and the broader healthcare infrastructure.
“That’s a lot of money,” Oz said. “And that bankrupts not just hospital systems and physician groups, but it causes major problems across the entire system.”
Addressing the issue is not merely about recovering misused funds—it is about safeguarding the integrity of the healthcare system for patients and future generations.
Efforts to dismantle these schemes remain relentless, with enforcement actions continuing without pause.
